ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts by Zhiwei Li, Yiyan Yao, Tiezheng Qi, Zuowei Wu, Dingshan Deng, Dingshan Deng, Bolong Liu, Bolong Liu, Bolong Liu

Connect to this object online.

A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts by Dingshan Deng, Dingshan Deng, Xiaowen Li, Tiezheng Qi, Yuanqing Dai, Yuanqing Dai, Neng Liu, Neng Liu, Huihuang Li, Huihuang Li

Connect to this object online.

Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer by Zhenyu Nie, Bolong Liu, Jinhui Liu, Xiongbing Zu, Juanhua Wang, Jinbo Chen, Benyi Fan, Dingshan Deng

Connect to this object online.

Molecular vasculogenic mimicry-Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts by Chunyu Zhang, Chunyu Zhang, Jiatong Xiao, Jiatong Xiao, Tong Yuan, Yunbo He, Dingshan Deng, Zicheng Xiao, Jinbo Chen, Xiongbing Zu, Peihua Liu, Peihua Liu, Zhi Liu, Zhi Liu

Connect to this object online.